"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Drug Antagonism

Drug antagonism occurs when one drug reduces or inhibits the effect of another drug. This phenomenon is crucial in pharmacology, as understanding antagonistic interactions can guide clinical use, manage side effects, and help avoid adverse drug interactions. Antagonism can occur through different mechanisms, each with specific examples and clinical relevance.


Types of Drug Antagonism

1. Pharmacological Antagonism

Competitive Antagonism:

The antagonist binds reversibly to the same receptor site as the agonist. Increasing the concentration of the agonist can overcome the antagonist's effects.

Example: Naloxone competitively antagonizes opioids at the mu-opioid receptor, reversing opioid overdose effects.

Non-Competitive Antagonism:

The antagonist binds to an allosteric site on the receptor, altering its shape so that the agonist cannot activate it. This effect cannot be overcome by increasing the agonist concentration.

Example: Ketamine acts as a non-competitive antagonist at the NMDA receptor, blocking excitatory neurotransmission and providing anesthetic effects.


2. Physiological (Functional) Antagonism

In physiological antagonism, two drugs produce opposing physiological effects by acting on different receptors or pathways.

Example: Epinephrine (a beta-agonist) counteracts the effects of histamine (acting on H1 receptors) in anaphylactic reactions, causing vasoconstriction and bronchodilation.


3. Chemical Antagonism

The antagonist directly interacts with the agonist in a chemical reaction, rendering the agonist inactive without involving receptor interactions.

Example: Protamine sulfate acts as a chemical antagonist to heparin by binding directly to it, neutralizing its anticoagulant effect.


4. Pharmacokinetic Antagonism

Pharmacokinetic antagonism occurs when one drug reduces the absorption, distribution, metabolism, or excretion of another drug.

Example: Phenobarbital increases the metabolic activity of liver enzymes (CYP450), accelerating the breakdown of warfarin and decreasing its anticoagulant effect.


5. Indirect Antagonism

Here, the antagonist inhibits a response by acting at a different site from where the agonist produces its effect.

Example: Calcium channel blockers reduce the response to norepinephrine by blocking calcium influx necessary for muscle contraction.


6. Receptor Desensitization and Downregulation

With repeated exposure, receptors may become less responsive (desensitized) or reduced in number (downregulated), leading to a decreased response.

Example: Continuous use of beta-agonists like albuterol can lead to beta-receptor desensitization in the airways.


Clinical Importance of Drug Antagonism

Understanding drug antagonism is vital for:

  • Therapeutic Reversal: Used to counteract overdoses (e.g., naloxone for opioids).
  • Side Effect Management: Antagonists can mitigate unwanted effects (e.g., antihistamines for allergic reactions).
  • Drug Interactions: Awareness of antagonistic interactions helps avoid reduced therapeutic efficacy or toxicity in polypharmacy.

© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed